Measurement of pancreatic fat by magnetic resonance imaging: Predicting the occurrence of pancreatic fistula after pancreatoduodenectomy

Annals of Surgery

Volumn 251, Issue 5, 2010, Pages 932-936

  Lee, Seung Eun ^a   Jang, Jin Young ^a   Lim, Chang Sup ^a   Kang, Mee Joo ^a   Kim, Se Hyung ^a   Kim, Min A ^a   Kim, Sun Whe ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FAMOTIDINE; LIPID; OCTREOTIDE;

ADULT; ARTICLE; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIPID ANALYSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS FISTULA; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SURGEON;

ADIPOSE TISSUE; AGED; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PANCREAS; PANCREATIC FISTULA; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 77951667778     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181d65483     Document Type: Article

References (26)

1. de Castro SM, Busch OR, van Gulik TM, et al. Incidence and management of pancreatic leakage after pancreatoduodenectomy. Br J Surg. 2005;92:1117-1123.
2. van Berge Henegouwen MI, De Wit LT, Van Gulik TM, et al. Incidence, risk factors, and treatment of pancreatic leakage after pancreatoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg. 1997; 185:18-24.
3. Hosotani R, Doi R, Imamura M. Duct-to-mucosa pancreaticojejunostomy reduces the risk of pancreatic leakage after pancreatoduodenectomy. World J Surg. 2002;26:99-104.
4. Lin JW, Cameron JL, Yeo CJ, et al. Risk factors and outcomes in postpan-creaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg. 2004;8:951-959.
5. Miedema BW, Sarr MG, van Heerden JA, et al. Complications following pancreaticoduodenectomy. Current Manag Arch Surg. 1992;127:945-949.
6. Yeo CJ, Cameron JL, Maher MM, et al. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduo- denectomy. Ann Surg. 1995;222:580-588.
7. Fujino Y, Suzuki Y, Ajiki T, et al. Risk factors influencing pancreatic leakage and the mortality after pancreaticoduodenectomy in a medium-volume hospital. Hepatogastroenterology. 2002;49:1124-1129.
8. Mathur A, Pitt HA, Marine M, et al. Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg. 2007;246:1058-1064.
9. Scatarige JC, Scott WW, Donovan PJ, et al. Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation. J Ultrasound Med. 1984;3:9-14.
10. Taylor KJ, Riely CA, Hammers L, et al. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat. Radiology. 1986;160:65-71.
11. Levenson H, Greensite F, Hoefs J, et al. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1. 5 T vs biopsy. Am J Roentgenol. 1991;156:307-312.
12. Longo R, Pollesello P, Ricci C, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging. 1995;5:281-285.
13. Limanond P, Raman SS, Lassman C, et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology. 2004;230:276-280.
14. Raeder H, Haldorsen IS, Ersland L, et al. Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxylester lipase. Diabetes. 2007;56:444-449.
15. Kovanlikaya A, Mittelman SD, Ward A, et al. Obesity and fat quantification in lean tissues using three-point Dixon MR imaging. Pediatr Radiol. 2005; 35:601-607. (Pubitemid 40724032)
16. Schwenzer NF, Machann J, Martirosian P, et al. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol. 2008;43:330-337.
17. Kim SH, Lee JM, Han JK, et al. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging-correlation with his-topathologic findings. Radiology. 2006;240:116-129.
18. Bassi C, Dervenis C, Butturini G, et al; International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8-13.
19. Lee SE, Yang SH, Jang JY, et al. Pancreatic fistula after pancreaticoduode-nectomy: a comparison between the two pancreaticojejunostomy methods for approximating the pancreatic parenchyma to the jejunal seromuscular layer: interrupted vs continuous stitches. World J Gastroenterol. 2007;13:5351-5356.
20. Merkle EM, Nelson RC. Dual gradient-echo in-phase and opposed-phase hepatic MR imaging: a useful tool for evaluating more than fatty infiltration or fatty sparing. Radiographics. 2006;26:1409-1418.
21. Mitchell DG. Focal manifestations of diffuse liver disease at MR imaging. Radiology. 1992;185:1-11.
22. Rofsky NM, Weinreb JC, Ambrosino MM, et al. Comparison between in-phase and opposed-phase T1-weighted breath-hold FLASH sequences for hepatic imaging. J Comput Assist Tomogr. 1996;20:230-235.
23. Earls JP, Krinsky GA. Abdominal and pelvic applications of opposed-phase MR imaging. Am J Roentgenol. 1997;169:1071-1077.
24. Hussain SM, Zondervan PE, IJzermans JN, et al. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radio-graphics. 2002;22:1023-1036.
25. Suzuki Y, Fujino Y, Tanioka Y, et al. Selection of pancreaticojejunostomy techniques according to pancreatic texture and duct size. Arch Surg. 2002; 137:1044-1047.
26. Sato N, Yamaguchi K, Chijiiwa K, et al. Risk analysis of pancreatic fistula after pancreatic head resection. Arch Surg. 1998;133:1094-1098.